0 Комментарии
0 Поделились
2Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Innovations Driving the Catheters and Active Implantable CDMO MarketThe Catheters and Active Implantable CDMO Market is expanding rapidly as healthcare systems worldwide prioritize minimally invasive procedures and advanced implantable devices. Contract Development and Manufacturing Organizations (CDMOs) are essential in this growth, providing medical device companies with scalable production, regulatory expertise, and research-driven innovation. The China...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Regional Insights on Catheters and Active Implantable CDMO MarketThe Catheters and Active Implantable CDMO Market is witnessing robust growth as regional dynamics and local healthcare infrastructure play a key role in shaping demand. The China Catheters Active Implantable CDMO Market and India Catheters Active Implantable CDMO Market are emerging as leaders in contract manufacturing, supported by government initiatives, skilled workforce, and increasing...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Medical Device Contract Development and Manufacturing Organization Market Expansion Through Digital Manufacturing TechnologiesThe global Medical Device Contract Development and Manufacturing Organization (CDMO) market was valued at USD 134.7 billion in 2025 and is projected to grow from USD 148.8 billion in 2026 to USD 352.6 billion by 2033, registering a CAGR of 13.1% from 2026 to 2033. North America dominated the market with a revenue share of 48.8% in 2025, reflecting the region’s strong medical...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Pharmaceutical Contract Manufacturing Market Share Across Global RegionsThe global Pharmaceutical Contract Manufacturing Market size was valued at USD 141.7 billion in 2025 and is projected to grow from USD 155.1 billion in 2026 to USD 310.9 billion by 2033, registering a CAGR of 10.4% from 2026 to 2033. North America accounted for the largest market share of 38.44% in 2025, supported by a mature pharmaceutical ecosystem, robust R&D investments, and...0 Комментарии 0 Поделились 5 Просмотры 0 предпросмотр